Glucotab-Based Basal-Bolus Insulin Therapy for Inpatient Glycemic Control Using Insulin Degludec

被引：0
|
作者：
Mader, Julia K.
Baumann, Petra M.
Aberer, Felix
Hochfellner, Daniel A.
Simic, Amra
Bytyqi, Lirie
Poettler, Tina
Hoell, Bernhard
Fahrleitner-Pammer, Astrid
Pieber, Thomas
Beck, Peter
机构：
来源：
DIABETES | 2021年 / 70卷
关键词：
D O I：
10.2337/db21-700-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
700-P
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Basal-Bolus Insulin Protocols Enter the Computer Age
    Nancy J. Wei
    Deborah J. Wexler
    Current Diabetes Reports, 2012, 12 : 119 - 126
  • [42] Basal-bolus therapy with insulin detemir using the 303 algorithm in the US PREDICTIVE 303 trial
    Jean-Louis Selam
    Luigi F. Meneghini
    Advances in Therapy, 2009, 26 : 194 - 207
  • [43] Cost-effectiveness of insulin degludec compared with insulin glargine in a basal-bolus regimen in patients with type 1 diabetes mellitus in the UK
    Evans, M.
    Wolden, M.
    Gundgaard, J.
    Chubb, B.
    Christensen, T.
    JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (01) : 56 - 68
  • [44] A 1-year, prospective, observational study of Japanese outpatients with type 1 and type 2 diabetes switching from insulin glargine or detemir to insulin degludec in basal-bolus insulin therapy (Kumamoto Insulin Degludec Observational study)
    Shimoda, Seiya
    Sato, Miki
    Sekigami, Taiji
    Motoshima, Hiroyuki
    Yoshimura, Ryohei
    Fukuda, Kazuki
    Matsuo, Yasuto
    Noda, Hideyuki
    Okubo, Mina
    Ichimori, Shinji
    Fujisawa, Kazuo
    Fukunaga, Makiko
    Araki, Eiichi
    JOURNAL OF DIABETES INVESTIGATION, 2016, 7 (05) : 703 - 710
  • [45] Basal-bolus therapy with insulin detemir using the 303 algorithm in the US PREDICTIVE 303 trial
    Selam, Jean-Louis
    Meneghini, Luigi F.
    ADVANCES IN THERAPY, 2009, 26 (02) : 194 - 207
  • [46] Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN® Basal-Bolus Type 1): 2-year results of a randomized clinical trial
    Bode, B. W.
    Buse, J. B.
    Fisher, M.
    Garg, S. K.
    Marre, M.
    Merker, L.
    Renard, E.
    Russell-Jones, D. L.
    Hansen, C. T.
    Rana, A.
    Heller, S. R.
    DIABETIC MEDICINE, 2013, 30 (11) : 1293 - 1297
  • [47] Intensification of basal insulin therapy with step-wise addition of insulin aspart boluses compared with basal-bolus therapy: the FullSTEP study
    Rodbard, H.
    Visco, V. E.
    Andersen, H.
    Hiort, L. C.
    Shu, D. H. W.
    DIABETOLOGIA, 2013, 56 : S412 - S412
  • [48] The basal to total insulin ratio in outpatients with diabetes on basal-bolus regimen
    Castellano E.
    Attanasio R.
    Giagulli V.A.
    Boriano A.
    Terzolo M.
    Papini E.
    Guastamacchia E.
    Monti S.
    Aglialoro A.
    Agrimi D.
    Ansaldi E.
    Babini A.C.
    Blatto A.
    Brancato D.
    Casile C.
    Cassibba S.
    Crescenti C.
    De Feo M.L.
    Del Prete A.
    Disoteo O.
    Ermetici F.
    Fiore V.
    Fusco A.
    Gioia D.
    Grassi A.
    Gullo D.
    Lo Pomo F.
    Miceli A.
    Nizzoli M.
    Pellegrino M.
    Pirali B.
    Santini C.
    Settembrini S.
    Tortato E.
    Triggiani V.
    Vacirca A.
    Borretta G.
    Journal of Diabetes & Metabolic Disorders, 2018, 17 (2): : 393 - 399
  • [49] Mealtime insulin bolus adherence and glycemic control in adolescents on insulin pump therapy
    Engelina Spaans
    Kornelis J. J. van Hateren
    Klaas H. Groenier
    Henk J. G. Bilo
    Nanne Kleefstra
    Paul L. P. Brand
    European Journal of Pediatrics, 2018, 177 : 1831 - 1836
  • [50] Mealtime insulin bolus adherence and glycemic control in adolescents on insulin pump therapy
    Spaans, Engelina
    van Hateren, Kornelis J. J.
    Groenier, Klaas H.
    Bilo, Henk J. G.
    Kleefstra, Nanne
    Brand, Paul L. P.
    EUROPEAN JOURNAL OF PEDIATRICS, 2018, 177 (12) : 1831 - 1836
12345